An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.
Selective estrogen receptor modulators (SERMs) are effective therapeutics that preserve favorable actions of estrogens on bone and act as antiestrogens in breast tissue, decreasing the risk of vertebral fractures and breast cancer, but their potential in neuroprotective and procognitive therapy is l...
Enregistré dans:
Auteurs principaux: | Lawren VandeVrede, Ramy Abdelhamid, Zhihui Qin, Jaewoo Choi, Sujeewa Piyankarage, Jia Luo, John Larson, Brian M Bennett, Gregory R J Thatcher |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/92d1a967b51f498891eff088417ce0b8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neurogenic-dependent changes in hippocampal circuitry underlie the procognitive effect of exercise in aging mice
par: Xiaoqing Alice Zhou, et autres
Publié: (2021) -
Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
par: Ava Soltani Hekmat, et autres
Publié: (2021) -
Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1
par: Alessandro Peri, et autres
Publié: (2008) -
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
par: Robert W. Maitta, et autres
Publié: (2021) -
THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
par: Zahid Farooq Baig, et autres
Publié: (2018)